Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Echoing the scientific literature, they write of ipamorelin that we lack sufficient information to know whether the drug would cause harm if administered to humans via [injection]. The peptide pralmorelin (or GHRP-2) is clinically approved in Japan, but only as a way to diagnose adults who are deficient in growth hormone
Their furthest along indication is fatty liver disease
SLU-PP-332 Side Effects & Safety Bottom line: there is no human safety data for SLU-PP-332
According to the National Institutes of Health Office of Dietary Supplements, an estimated 6% of adults under 60 in the United States are B12 deficient, with the prevalence rising to nearly 20% in adults over 60
